Lethal activity of camptothecin sodium on human lymphoma cells
- PMID: 4814992
Item in Clipboard
Lethal activity of camptothecin sodium on human lymphoma cells
Cancer Res.
1974 Apr.
No abstract available
Similar articles
-
Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin.Bioorg Med Chem Lett. 2004 Aug 2;14(15):4023-6. doi: 10.1016/j.bmcl.2004.05.032. Bioorg Med Chem Lett. 2004. PMID: 15225719
-
First synthesis of novel spin-labeled derivatives of camptothecin as potential antineoplastic agents.Eur J Med Chem. 2008 Nov;43(11):2610-4. doi: 10.1016/j.ejmech.2008.01.008. Epub 2008 Jan 25. Eur J Med Chem. 2008. PMID: 18313176
-
Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.Cancer Res. 1994 Apr 1;54(7):1720-8. Cancer Res. 1994. PMID: 8137287
-
Anti-proliferative and pro-apoptotic effect of CPT13, a novel camptothecin analog, on human colon cancer HCT8 cell line.Chem Biol Interact. 2008 Nov 25;176(2-3):165-72. doi: 10.1016/j.cbi.2008.07.005. Epub 2008 Jul 30. Chem Biol Interact. 2008. PMID: 18708040
-
Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations.Cancer Res. 1995 Sep 15;55(18):4004-9. Cancer Res. 1995. PMID: 7664272
Cited by
-
Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.Jpn J Cancer Res. 1997 Feb;88(2):218-23. doi: 10.1111/j.1349-7006.1997.tb00369.x. Jpn J Cancer Res. 1997. PMID: 9119752 Free PMC article.
-
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.Br J Cancer. 1997;76(7):952-62. doi: 10.1038/bjc.1997.491. Br J Cancer. 1997. PMID: 9328159 Free PMC article. Review.
-
A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38.Jpn J Cancer Res. 1995 Jan;86(1):101-10. doi: 10.1111/j.1349-7006.1995.tb02994.x. Jpn J Cancer Res. 1995. PMID: 7737901 Free PMC article. Clinical Trial.
-
Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors.Cancer Res. 2011 Jun 1;71(11):3963-71. doi: 10.1158/0008-5472.CAN-10-0906. Epub 2011 Apr 4. Cancer Res. 2011. PMID: 21464045 Free PMC article.
-
Clinical studies of irinotecan alone and in combination with cisplatin.Cancer Chemother Pharmacol. 1994;34 Suppl:S105-11. doi: 10.1007/BF00684873. Cancer Chemother Pharmacol. 1994. PMID: 8070018 Clinical Trial.